AZ-ASU-PREP-DIGITAL
13.7.2022 13:02:07 CEST | Business Wire | Press release
ASU Prep Digital, an accredited online K-12 school offered through Arizona State University, has partnered with Google Public Sector, to make remote immersive learning technology more accessible to students across the United States and around the world. ASU Prep Learning Cloud is a streaming solution that empowers schools to deliver innovative and interactive 3D learning experiences to students using low-bandwidth devices. The technology was developed on and is powered by Google Cloud.
This new platform invites students to solve challenges by immersing themselves in interactive settings made possible by technology. For example, students can watch geologic formations emerge through simulations rather than reading about it in a textbook. Students can also explore human organs in 3D or examine a plastic mannequin. This brings topics like erosion, hydrolysis, and human anatomy to life.
To successfully complete a lesson, students must think critically about the concept, explore it, and learn through discovery. Real-time, instructive feedback also helps contribute to a more individualized learning experience.
“We’re turning students into explorers by embedding learning into the digital formats that students love,” said David Sudarma, ASU Prep’s chief technology officer. “We spark curiosity by asking students to navigate 3D worlds, hypothesize, and discover knowledge by manipulating game-like simulations to solve real-world problems.”
Advancing Accessibility
The ASU Prep Learning Cloud represents an important step toward accessibility for students in rural areas, with limited broadband access, and districts where limited technology funding makes it difficult to deliver cutting-edge learning opportunities. This immersive cloud-based education technology can be experienced from mobile devices or Chromebooks, increasing accessibility for all learners, anytime, anywhere. Removing those barriers is especially important for a program like ASU Digital Prep, which can be instrumental in bridging gaps for districts where resources are slim.
“ASU Prep Digital has allowed us to partner and advance educational opportunities for thousands of K-12 students who might not have otherwise had access to the courses, credits, mentors, and teachers we offer,” said Arizona State University President Michael Crow, who is widely known as a pioneer of online education.
Crow’s vision has created a tech-enhanced learning environment across ASU, inclusive of pre-collegiate students via ASU Prep Digital. A key element of that vision is expanded opportunities in online education, which offers a path to higher education for students who are otherwise hindered from pursuing their education goals. In addition to its rapidly expanding K-12 enrollment, ASU Prep Digital’s School Partnerships continue to grow. The program supports entire school districts in states like Utah, Louisiana and Ohio, as well as schools in 22 states and 12 countries.
Powerhouse Partnerships
In addition to the full- and part-time students who enroll directly with ASU Prep Digital, the school also teams with private schools, public schools, and districts worldwide to offer a K-12 curriculum and one-on-one instruction in a virtual environment. The program’s latest suite of courses, which will be available this fall to partner schools via the ASU Prep Learning Cloud, powered by Google Cloud, can be used in compliance with Family Educational Rights and Privacy Act (FERPA).
As pioneers in their respective industries, ASU Prep Digital and Google Public Sector worked to develop the platform, which is based on game engine technology. The ASU Prep Learning Cloud features responsive design optimized for the most commonly used devices (e.g., Chromebooks, mobile phones) using Web Content Accessibility Guidelines (WCAG).
“Our partnership with ASU Prep Digital has the ability to unlock new and innovative academic opportunities for learners across the country,” said Steven Butschi, director of Education, Google Public Sector. “We’re unleashing the power of Google Cloud to help make individualized, digital, and interactive learning the new standard in education.”
Courses integrate seamlessly into existing learning management systems, while supporting robust interactive features that personalize learning. The platform currently supports ASU Prep Digital partner schools, but in the future, could be rolled out to other educational institutions.
“As immersive technologies become more widely adapted in education, 3D learning environments such as augmented reality and virtual reality offer great potential for engagement and retention,” Sudarma said. “Our collaboration with Google Public Sector is a terrific first step in expanding access to immersive solutions across many devices, and we’re working together to explore ways immersive technologies can be made even more universally available to eager learners.”
To preview a snapshot of ASU Prep Learning Cloud courses, visit: https://vimeo.com/623494408 or take a deeper look at the immersive platform here: https://vimeo.com/689344144/795e785a7c
About ASU Prep Digital
ASU Prep Digital is an accredited online K-12 school that offers a single online course or enrollment in a full-time, diploma-granting program. Because it is part of Arizona State University, ASU Prep Digital offers an accelerated path toward college admission and the chance to earn concurrent high school and university credit. For more information, visit asuprepdigital.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005336/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
